Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 103.12M | $ 0 | $ 5.02M | 20.53 |
3/31/2025 | $ 116.81M | $ 0 | $ 19.43M | 6.01 |
12/31/2024 | $ 127.32M | $ 0 | $ 15.62M | 8.15 |
9/30/2024 | $ 132.78M | $ 0 | $ 18.92M | 7.02 |
6/30/2024 | $ 148.22M | $ 0 | $ 22.59M | 6.56 |
3/31/2024 | $ 135.87M | $ 0 | $ 20.3M | 6.69 |
12/31/2023 | $ 132.03M | $ 0 | $ 22.49M | 5.87 |
9/30/2023 | $ 141.61M | $ 0 | $ 22.32M | 6.34 |
6/30/2023 | $ 158.8M | $ 0 | $ 24.53M | 6.47 |
3/31/2023 | $ 152.85M | $ 0 | $ 25.15M | 6.08 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for ARBUTUS BIOPHARMA CORP is calculated as follows: (AssetsC [ $ 121.24M ] - Inventory [ $ 0 ]) / LiabilitesC [ $ 7.61M ]
(=) Quick Ratio [ 15.94 ]
Minimum
Dec 31, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |